These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32202052)

  • 1. Abnormal platelet phenotypes in patients with myelodysplastic syndromes.
    Liu J; Niu H; Yue L; Lv Q; Yang L; Liu C; Jiang H; Xing L; Shao Z; Wang H
    Int J Lab Hematol; 2020 Aug; 42(4):371-379. PubMed ID: 32202052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
    Sandes AF; Yamamoto M; Matarraz S; Chauffaille Mde L; Quijano S; López A; Oguro T; Kimura EY; Orfao A
    Haematologica; 2012 Jun; 97(6):895-902. PubMed ID: 22271903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
    Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Savopol T; Iordache MM; Moisescu MG
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.
    Psaila B; Bussel JB; Frelinger AL; Babula B; Linden MD; Li Y; Barnard MR; Tate C; Feldman EJ; Michelson AD
    J Thromb Haemost; 2011 Nov; 9(11):2302-10. PubMed ID: 21920014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function in the myelodysplastic syndromes.
    Mittelman M; Zeidman A
    Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM; Vasilache V; Bumbea H; Onisâi M
    Rom J Intern Med; 2011; 49(1):93-6. PubMed ID: 22026258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study.
    Wu YF; Gu MH; Liu CZ; Huang WH; Chu SC; Wang TF
    PLoS One; 2022; 17(11):e0278040. PubMed ID: 36409726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes.
    Liu P; Jiang H; Che M; Fu R; Wang H; Li L; Zhang W; Tao J; Gao S; Shao Z
    Leuk Res; 2018 Apr; 67():12-16. PubMed ID: 29407181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes.
    Cheok KPL; Chhetri R; Wee LYA; Friel O; Pham A; Salvi A; McRae S; Bardy P; Singhal D; Roxby DJ; Wood EM; Hiwase DK
    Transfusion; 2020 Oct; 60(10):2192-2198. PubMed ID: 32905635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders.
    Connor DE; Ma DD; Joseph JE
    Thromb Res; 2013 Nov; 132(5):572-7. PubMed ID: 24094604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between syndrome differentiation-typing and expression of platelet-activation molecule CD62P and CD63 on platelets in psoriatic patients].
    Li GY; Liu HC; Yin GP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Jul; 17(7):417-8. PubMed ID: 10322863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of activation-dependent platelet antigens CD62p and CD63 during haemodialysis.
    Gutensohn K; Sputtek A; Voss A; Stahl RA; Kuehnl P
    Transfus Sci; 1996 Dec; 17(4):489-92. PubMed ID: 10168544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry in the diagnosis of myelodysplastic syndromes and the value of myeloid nuclear differentiation antigen.
    Bellos F; Kern W
    Cytometry B Clin Cytom; 2017 May; 92(3):200-206. PubMed ID: 26184452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
    Itzykson R; Crouch S; Travaglino E; Smith A; Symeonidis A; Hellström-Lindberg E; Sanz G; Čermák J; Stauder R; Elena C; Germing U; Mittelman M; Langemeijer S; Mądry K; Tatic A; Holm MS; Almeida AM; Savic A; Šimec NG; Luño E; Culligan D; Guerci-Bresler A; Malcovati L; van Marrewijk C; Bowen D; de Witte T; Fenaux P;
    Blood Adv; 2018 Aug; 2(16):2079-2089. PubMed ID: 30126931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of platelet activation markers after ischemic stroke.
    Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
    Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of platelet activation by flow cytometry in patients with pre-eclampsia].
    Yi ZS; Zhou SY; Meng FY; Feng R; Liu QF; Lin R
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1095-6. PubMed ID: 14559705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet mass has prognostic value in patients with myelodysplastic syndromes.
    Bowles KM; Warner BA; Baglin TP
    Br J Haematol; 2006 Oct; 135(2):198-200. PubMed ID: 16939490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.